TARIQ SHAFI to Diabetic Nephropathies
This is a "connection" page, showing publications TARIQ SHAFI has written about Diabetic Nephropathies.
Connection Strength
0.691
-
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
Score: 0.217
-
Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes. J Am Soc Nephrol. 2025 Oct 01; 36(10):2061-2076.
Score: 0.206
-
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Nephrol Dial Transplant. 2023 11 30; 38(12):2809-2815.
Score: 0.187
-
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S92-8.
Score: 0.045
-
Performance of Indexed and Nonindexed Estimated GFR. Am J Kidney Dis. 2020 09; 76(3):446-449.
Score: 0.037